Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CLCN2 | P51788 | 1/20 | 0.54 |
| ▸ | TSHR | P16473 | 1/20 | 0.50 |
| ▸ | MRGPRX4 | Q96LA9 | 1/20 | 0.50 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.48 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.48 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.48 |
| ▸ | HPGD | P15428 | 1/20 | 0.48 |
| ▸ | GABRA1 | P14867 | 1/20 | 0.46 |
| ▸ | GABRB2 | P47870 | 1/20 | 0.46 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.46 |
| ▸ | HMGB1 | P09429 | 1/20 | 0.46 |
| ▸ | FOLH1 | Q04609 | 1/20 | 0.46 |
| ▸ | HTT | P42858 | 1/20 | 0.45 |
| ▸ | MYC | P01106 | 2/20 | 0.44 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.43 |
| ▸ | MEN1 | O00255 | 1/20 | 0.43 |
| ▸ | AKR1B10 | O60218 | 1/20 | 0.43 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.43 |
| ▸ | ABCB11 | O95342 | 1/20 | 0.43 |
| ▸ | DHFR | P00374 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Benzene SCHEMBL28861692 | 1.00 | CLCN2 (0.54) | CLCN2TSHRMRGPRX4ALDH1A1KDM4E | |
| SCHEMBL2362450 | 0.86 | MRGPRX4 (0.47) | CLCN2TSHRMRGPRX4ALDH1A1KDM4E | |
| SCHEMBL2652419 | 0.86 | PDCD1 (0.53) | CLCN2TSHRMRGPRX4ALDH1A1KDM4E | |
| SCHEMBL28708772 | 0.85 | GABRA1 (0.48) | CLCN2TSHRMRGPRX4ALDH1A1HSD17B10 | |
| SCHEMBL8179315 | 0.84 | AKR1B1 (0.48) | CLCN2TSHRMRGPRX4ALDH1A1KDM4E | |
| SCHEMBL15206277 | 0.84 | MRGPRX4 (0.48) | CLCN2TSHRMRGPRX4ALDH1A1KDM4E | |
| SCHEMBL6617739 | 0.84 | MRGPRX4 (0.51) | CLCN2TSHRMRGPRX4ALDH1A1KDM4E | |
| SCHEMBL18049144 | 0.84 | HMGB1 (0.51) | CLCN2TSHRMRGPRX4ALDH1A1KDM4E | |
| SCHEMBL7963839 | 0.84 | FOLH1 (0.52) | CLCN2TSHRMRGPRX4ALDH1A1KDM4E | |
| SCHEMBL19748199 | 0.84 | MRGPRX4 (0.48) | CLCN2TSHRMRGPRX4ALDH1A1KDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 295 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119301224-A | 2-Methylbenzoic acid ethyl ester as perfume | 西姆莱斯股份公司 | 2025-01-10 | — | — | CN | claimed |
| CN-117486712-A | Flash separation process of m-methylbenzoic acid | 常州大学 | 2024-02-02 | — | — | CN | claimed |
| US-8569195-B2 | Internal and external donor compounds for olefin polymerization catalysts II | BASF CORPORATION (US) | 2013-10-29 | — | — | US | claimed |
| EP-2539375-A2 | INTERNAL AND EXTERNAL DONOR COMPOUNDS FOR OLEFIN POLYMERIZATION CATALYSTS II | BASF Corporation (US) | 2013-01-02 | — | — | EP | claimed |
| WO-2011106480-A2 | INTERNAL AND EXTERNAL DONOR COMPOUNDS FOR OLEFIN POLYMERIZATION CATALYSTS II | BASF CORPORATION (US) | 2011-09-01 | — | — | WO | claimed |
| US-20110207901-A1 | INTERNAL AND EXTERNAL DONOR COMPOUNDS FOR OLEFIN POLYMERIZATION CATALYSTS II | BASF CATALYSTS LLC (US) | 2011-08-25 | — | — | US | claimed |
| JP-5186646-A | — | — | None | — | — | JP | disclosed |
| CN-119301224-A | 2-Methylbenzoic acid ethyl ester as perfume | 西姆莱斯股份公司 | 2025-01-10 | — | — | CN | disclosed |
| CN-117530943-A | Formulations for administration of efluromithine | 奥巴斯治疗股份有限公司 | 2024-02-09 | — | — | CN | disclosed |
| US-11834456-B2 | 11,13-modified saxitoxins for the treatment of pain | SITEONE THERAPEUTICS, INC. (US) | 2023-12-05 | — | — | US | disclosed |
| CN-111164084-B | Triazolotriazine derivatives useful as A2A receptor antagonists | 浙江春禾医药科技有限公司 | 2023-05-23 | — | — | CN | disclosed |
| CN-116139138-A | Heterocyclic modulators of lipid synthesis | 3-V生物科学股份有限公司 | 2023-05-23 | — | — | CN | disclosed |
| CN-115210221-A | Isoxazoline derivatives as pesticides | 礼蓝动物保健有限公司 | 2022-10-18 | — | — | CN | disclosed |
| EP-0736552-A2 | Propylene homopolymer | AMOCO CORPORATION (US) | 1996-10-09 | — | — | EP | disclosed |
| US-5430023-A | Tripeptide antithrombotic agents | ELI LILLY AND COMPANY (US) | 1995-07-04 | — | — | US | disclosed |
| JP-H05186646-A | POLYPROPYLENE-BASED RESIN COMPOSITION | TOSOH CORP | 1993-07-27 | — | — | JP | disclosed |
| US-5218052-A | Increased stiffness and broadend molecular weight distribution | AMOCO CORPORATION (US) | 1993-06-08 | — | — | US | disclosed |
| EP-0507576-A1 | Polypropylene-based resin compositions | TOSOH CORPORATION (JP) | 1992-10-07 | — | — | EP | disclosed |
| EP-0498603-A2 | Olefin polymerization and copolymerization process | AMOCO CORPORATION (US) | 1992-08-12 | — | — | EP | disclosed |
| US-4467115-A | Method for preparing branched polyethylenimine | INSTITUT NEFTEKHIMICHESKOGO SINTEZA IMENI A.V. TONCHEVA AKADEMII NAUK SSSR (SU) | 1984-08-21 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11834456-B2 | 11,13-modified saxitoxins for the treatment of pain | SCN11A, SCN10A, CACNA1A | CLCN2 372/4885TSHR 2253/4885MRGPRX4 208/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.